Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Clinical features of depressed patients who do and do not improve with placebo.

Brown WA, Johnson MF, Chen MG.

Psychiatry Res. 1992 Mar;41(3):203-14.

PMID:
1594707
2.

Placebo response in depression: a search for predictors.

Brown WA, Dornseif BE, Wernicke JF.

Psychiatry Res. 1988 Dec;26(3):259-64.

PMID:
3065807
3.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
4.

Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.

Isaac MT, Isaac MB, Gallo F, Tournoux A.

Hum Psychopharmacol. 2003 Dec;18(8):595-601.

PMID:
14696018
6.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.

J Clin Psychiatry. 1991 Aug;52(8):329-35.

PMID:
1907963
7.

Time course of improvement under antidepressant treatment: a survival-analytical approach.

Stassen HH, Delini-Stula A, Angst J.

Eur Neuropsychopharmacol. 1993 Jun;3(2):127-35. Erratum in: Eur Neuropsychopharmacol 1993 Dec;3(4):543.

PMID:
8364348
8.

Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.

Ucha Udabe R, Márquez CA, Traballi CA, Portes N.

Acta Psychiatr Scand Suppl. 1990;360:54-6.

PMID:
2123367
9.

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.

Khan A, Brodhead AE, Kolts RL, Brown WA.

J Psychiatr Res. 2005 Mar;39(2):145-50.

PMID:
15589562
10.

The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.

Zhang ZJ, Tan QR, Tong Y, Li Q, Kang WH, Zhen XC, Post RM.

J Affect Disord. 2008 Jul;109(1-2):91-7. Epub 2008 Feb 21.

PMID:
18093662
11.

A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.

Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF.

J Clin Psychiatry. 1995;56 Suppl 6:30-6.

PMID:
7649971
12.

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.

Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.

Eur Neuropsychopharmacol. 2008 Nov;18(11):803-13. doi: 10.1016/j.euroneuro.2008.06.006. Epub 2008 Aug 9.

PMID:
18694635
13.

Factors that influence the outcome of placebo-controlled antidepressant clinical trials.

Niklson IA, Reimitz PE, Sennef C.

Psychopharmacol Bull. 1997;33(1):41-51.

PMID:
9133750
14.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW.

J Clin Psychopharmacol. 2008 Dec;28(6):631-7. doi: 10.1097/JCP.0b013e31818a6cea.

PMID:
19011431
15.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
17.

Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.

Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.

Acta Psychiatr Scand Suppl. 1990;360:42.

PMID:
2248066
18.
19.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
20.

Which depressions respond to placebo?

Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M.

Psychiatry Res. 1986 Jul;18(3):217-26.

PMID:
3529150

Supplemental Content

Support Center